Kratom and the FDA: Regulatory Status and Safety Concerns

By KratomCBDDirect.com Editorial Team

Editorial disclosure: This article provides general health education. It is not sponsored by any product manufacturer. We may earn commissions from links on this page at no extra cost to you.

Reader Brief

Topic: Kratom and the FDA: Regulatory Status and Safety Concerns

Evidence boundary: Published clinical literature and regulatory guidance. General education only.

What this covers: Key facts about kratom and the fda: regulatory status and safety concerns

What Kratom Is and How It Works

Kratom (Mitragyna speciosa) is a tropical tree from Southeast Asia whose leaves contain mitragynine and 7-hydroxymitragynine, compounds that interact with opioid receptors. At low doses, it has stimulant-like effects; at higher doses, it produces opioid-like effects including pain relief and sedation. The FDA has not approved kratom for any medical use and has expressed significant safety concerns.

Current Regulatory Landscape

The FDA has issued multiple warnings about kratom, citing risks of addiction, abuse, and death. The DEA considered scheduling kratom as a controlled substance but withdrew the proposal after public comment. Kratom remains legal at the federal level but is banned in several states and localities. The Kratom Consumer Protection Act, adopted in some states, attempts to regulate quality and labeling without banning the substance.

Known Risks and Unknowns

Documented risks include: dependence and withdrawal symptoms with regular use, contamination with salmonella and heavy metals in some products, interactions with other substances especially opioids and benzodiazepines, and cases of liver toxicity. The lack of standardization means potency varies significantly between products and batches. People using kratom for opioid withdrawal should do so under medical supervision.

Practical Takeaways

Kratom is NOT FDA-approved for any medical use
Dependence and withdrawal are documented risks
Product quality varies significantly between vendors
Do not combine with opioids or benzodiazepines
Seek medical supervision if using for opioid withdrawal
Report adverse effects to FDA MedWatch

Evidence Context and Limitations

The information in this article draws from published clinical literature, regulatory guidance, and established medical consensus. Health research is continually evolving, and current understanding may be updated as new studies are published. Individual circumstances vary, and this general education does not account for your specific health history, medications, or conditions. Always verify current information with your healthcare provider, especially before making changes to medications, supplements, or health routines.

How to Use This Information

Authoritative Sources

FDA Import Alerts and State-Level Kratom Regulation

The U.S. Food and Drug Administration has maintained Import Alert 54-15 since 2014, which allows detention without physical examination of dietary supplements and bulk dietary ingredients that are or contain kratom. This import alert does not make kratom illegal to possess or sell in all cases, but it authorizes customs officials to detain incoming shipments on the basis that the product appears to be an unapproved new drug, a misbranded dietary supplement, or an adulterated food product. The FDA has also issued multiple warning letters to kratom vendors making therapeutic claims, particularly claims about pain relief, opioid withdrawal treatment, or mood enhancement.

At the state level, kratom regulation varies significantly. As of mid-2026, several states have enacted the Kratom Consumer Protection Act, which does not ban kratom but requires product registration, good manufacturing practices, age restrictions, and labeling standards including disclosure of mitragynine and 7-hydroxymitragynine content. Other states or municipalities have banned kratom entirely. Consumers should verify the legal status in their specific state and locality before purchasing. Product adulteration remains a documented concern: the FDA has identified kratom products contaminated with heavy metals, and in some cases, products marketed as kratom have been found to contain synthetic opioids not declared on the label.

KCPA Compliance and Vendor Verification

In states that have adopted the Kratom Consumer Protection Act, vendors must register their products, demonstrate adherence to good manufacturing practices, and ensure that products are free from dangerous contaminants and synthetic additives. The KCPA framework typically requires labels to disclose the amounts of mitragynine and 7-hydroxymitragynine per serving, list all ingredients, and display a batch or lot number that can be traced to laboratory testing records. Products that omit this information in KCPA states may be noncompliant.

Consumers can verify vendor claims by checking whether the company is registered with the relevant state agency, whether batch-specific lab results are publicly available and match the lot number on the product, and whether the testing laboratory is independent from the manufacturer. Third-party GMP audits from organizations such as the American Kratom Association's GMP Standards Program provide an additional layer of verification, though membership in an industry trade group should be evaluated alongside, not instead of, independent test results. Products imported from Southeast Asia pass through multiple handlers between harvest and retail, and each transfer point introduces potential for contamination, adulteration, or mislabeling.

Bottom Line

Kratom carries real risks including dependence and drug interactions. The regulatory landscape is evolving. Medical supervision is strongly recommended.

This page provides general education and does not diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare provider before starting any supplement or medication.

This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.